Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bespoke Extracts (BSPK) Shares Outstanding (Weighted Average) (2017 - 2025)

Bespoke Extracts (BSPK) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $11.2 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 8.31% to $11.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Sep 2025, up 8.31% year-over-year, with the annual reading at $10.5 million for FY2024, 3.54% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $11.2 million in Q3 2025 for Bespoke Extracts, roughly flat from $11.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $247.3 million in Q4 2021 to a low of $5.2 million in Q3 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $45.3 million across 5 years, with a median of $10.2 million in 2023.
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 115.19% in 2021; the steepest drop was 95.66% in 2021.
  • Year by year, Shares Outstanding (Weighted Average) stood at $247.3 million in 2021, then plummeted by 96.21% to $9.4 million in 2022, then rose by 8.55% to $10.2 million in 2023, then increased by 3.54% to $10.5 million in 2024, then increased by 6.25% to $11.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BSPK at $11.2 million in Q3 2025, $11.2 million in Q2 2025, and $11.2 million in Q1 2025.